A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care.
To determine the clinical effectiveness and cost-effectiveness of topical mometasone in children with bilateral otitis media with effusion (OME). A double-blind randomised placebo-controlled trial with an intention to treat analysis; the 10.6% of patients lost to follow-up at 1 month were censored i...
Hoofdauteurs: | Williamson, I, Benge, S, Barton, S, Petrou, S, Letley, L, Fasey, N, Abangma, G, Dakin, H, Little, P |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2009
|
Gelijkaardige items
-
A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care
door: Williamson, I, et al.
Gepubliceerd in: (2009) -
A double-blind randomised placebo-controlled trial of topical intranasal corticosteroids in 4- to 11-year-old children with persistent bilateral otitis media with effusion in primary care.
door: Williamson, I, et al.
Gepubliceerd in: (2009) -
Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial.
door: Petrou, S, et al.
Gepubliceerd in: (2010) -
Mapping analyses to estimate health utilities based on responses to the OM8-30 Otitis Media Questionnaire.
door: Dakin, H, et al.
Gepubliceerd in: (2010) -
Oral steroids for resolution of otitis media with effusion in children (OSTRICH): a double-blinded, placebo-controlled randomised trial
door: Francis, N, et al.
Gepubliceerd in: (2018)